Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Expression data from mobilized human CD34+ cells


ABSTRACT: Bortezomib-based secondary induction therapy and mobilization could represent alternative strategies to reduce tumor burden. We used microarrays to investigate genome-wide expression changes between bortezomib and non-bortzomib mobilizaton strategies and identified distinct genes and pathways that were significantly differentially regulated. CD34+ stem cells were enriched from leukapheresis products from multiple myeloma patients treated with a bortezomib- or non-bortezomib-based mobilization. RNA extraction, amplification and hybridization on Affymetrix microarrays was performed. Post-induction stem cell collection was initiated when patients' ANC reached >1.0M-CM-^W10^9/L.

ORGANISM(S): Homo sapiens

SUBMITTER: Maureen Lane 

PROVIDER: E-GEOD-43124 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2015-05-18 | E-GEOD-63520 | biostudies-arrayexpress
2011-11-22 | E-GEOD-30931 | biostudies-arrayexpress
2013-02-13 | GSE43124 | GEO
2010-07-20 | E-GEOD-22594 | biostudies-arrayexpress
2008-06-14 | E-GEOD-11771 | biostudies-arrayexpress
2011-11-22 | E-GEOD-31118 | biostudies-arrayexpress
2014-08-01 | E-MTAB-2666 | biostudies-arrayexpress
2011-06-04 | E-GEOD-29713 | biostudies-arrayexpress
2015-11-04 | E-GEOD-74634 | biostudies-arrayexpress
2013-11-01 | E-GEOD-51940 | biostudies-arrayexpress